MedSwitcher
Not FDA-ApprovedInjectable vial (subcutaneous)

Compounded Tirzepatide

tirzepatide (compounded) · Various compounding pharmacies

Choose your next step

Research the details now, then get alerts and treatment options for Compounded Tirzepatide when you are ready to act.

Get Compounded Tirzepatide pricing and access updates by email

Key Facts

Form

Injectable vial (subcutaneous)

Frequency

Once weekly

Available Doses

2.5mg5mg7.5mg10mg12.5mg15mg

Mechanism

Dual GLP-1 + GIP receptor agonist (compounded)

Manufacturer

Various compounding pharmacies

Cost

Self-Pay

$199-399/mo

Never covered by insurance. Tirzepatide remains on FDA shortage list as of April 2026, so compounding is still legal, but Lilly litigation creates uncertainty.

Side Effects

Side EffectRateSource
NauseaSimilar to brand-name tirzepatideExtrapolated from brand data
DiarrheaSimilar to brand-name tirzepatideExtrapolated from brand data
VomitingSimilar to brand-name tirzepatideExtrapolated from brand data
Injection site reactionsMay be higher due to formulation differencesFDA warnings

Source: No independent clinical trials for compounded formulations. Side effect data extrapolated from brand-name tirzepatide trials.

How It Works

If properly compounded, it works identically to brand-name tirzepatide (Mounjaro/Zepbound). The same quality concerns apply as with compounded semaglutide — potency, sterility, and stability may vary significantly.

Mechanism: Compounded tirzepatide is the same molecule as Mounjaro/Zepbound, produced by compounding pharmacies. As of early April 2026, tirzepatide REMAINS on the FDA shortage list, meaning compounding is still broadly legal for both 503A and 503B pharmacies. However, Eli Lilly has pursued legal action against some compounders, and the regulatory landscape remains uncertain.

Who It's For

Indication

Used for weight loss and diabetes (off-label compounded use)

Patients currently on compounded tirzepatide should monitor the regulatory situation. Tirzepatide remains on the FDA shortage list (as of April 2026), but Lilly litigation and potential shortage list changes create uncertainty. Consider planning a transition to FDA-approved alternatives (Zepbound, Mounjaro, or Foundayo). Not recommended for new patients.

Food & Water Restrictions

✅ No Restrictions

This medication can be taken at any time of day, with or without food and water.

Switching Guides

Helpful Articles

Compounded Tirzepatide fact review snapshot
Medication
Compounded Tirzepatide
Tracked facts
8
Human verified
0
Last refreshed: 2026-04-07

This page pulls from MedSwitcher's structured medication fact database. Facts are tracked separately from page copy so we can update sources, pricing, and trial details without guessing.

Primary source trail
  • FDA compounding guidance
  • Market pricing summary

Want the boring but important details? Read our editorial policy and methodology.

Don't miss price changes

GLP-1 prices are changing — stay ahead

Foundayo prices may increase — get alerts before they do. Track price drops, shortages, and new switching guidance without checking back manually.

  • Price increase warnings before they hit
  • Savings card and coupon alerts
  • New switching guidance and availability updates

No spam. Unsubscribe anytime. We never share your email.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Clinical trial data referenced comes from published studies and FDA prescribing information. Side effect rates are from specific clinical trials and may not reflect real-world experience. Always consult your healthcare provider before starting, stopping, or switching any medication.

⚠️ This medication is not FDA-approved. Quality, potency, and safety may vary. Discuss risks with your healthcare provider.